Summary
The distribution in the dog prostate and other tissues of ciprofloxacin, a quinoline carboxylic acid derivative, was investigated in an experimental model. The concentrations in prostatic tissue, prostatic interstitial fluid (PIF), and prostatic secretion (PS) were lower than the corresponding plasma (P) concentrations, as would be expected for an acidic compound. The experiments were carried out under steady state conditions during intravenous infusion in one group of dogs and following gastric administration in another group. During steady state the ciprofloxacin concentrations were significantly higher in PS than in PIF, and the median PS/P ratios were significantly higher than the PIF/P ratios. These concentrations and ratios were compared with those of two other quinoline carboxylic acid derivatives, rosoxacin and norfloxacin. The concentrations of ciprofloxacin in prostatic tissue, PIF, PS, and urine were several times higher than the minimum inhibitory concentrations for most gram-negativve pathogen that cause bacterial prostatitis and urinary tract infections. Clinical trials of ciprofloxacin in these diseases are therefore indicated.
Similar content being viewed by others
References
Baumeller A, Madsen PO (1977) Experimental bacterial prostatitis in dogs. Urol Res 5:211–213
Crump B, Wise R, Dent J (1983) Pharmacokinetics and tissue penetration of ciprofloxatin. Antimicrob Agents Chemother 24:784–786
Fair WR, Cordonnier JJ (1978) The pH of prostatic fluid: a reappraisal and therapeutic implication. J Urol 120:695–698
Fass RJ (1983) In vitro activity of ciprofloxacin (Bay 09867). Antimicrob Agents Chemother 24:568–574
Jensen KM-E, Madsen PO (1983) Distribution of quinoline carboxylic acid derivatives in the dog prostate. Prostate 4:407–414
Madsen PO, Baumueller A, Hoyme U (1978) Experimental models for determination of antimicrobials in prostatic tissue, interstitial fluid and secretion. Scand J Infest Dis, Suppl 14: 145–150
Meares EM (1980) Prostatitis syndromes: new perspectives about old woes. J Urol 123:141–147
Meares EM, Stamey TA (1968) Bacteriologic localization patterns in bacterial prostatitis and urethritis. Invest Urol 5: 492–518
Miles Pharmaceuticals Medical Research (1982) Informational material for the investigational drug ciprofloxacin (Bay 09867). Investigator's brochure. West Haven, CT
Muijtens HL, van der Ros-van de Repe J, van Veldhuizen G (1983) Comparative activities of ciprofloxacin (Bay 09867), norfloxacin, pipemidic acid, and nalidixic acid. Anitmicrob Agents Chemother 24:302–304
Stamey TA, Meares EM, Winnigham DG (1970) Chronic bacterial prostatitis and the diffusion of drugs into prostatic fluid. J Urol 103:187–194
Wise R, Andrews JM, Edwards LJ (1983) In vitro activity of Bay 09867, a new quinoline derivative, compared with those of other antimicrobial agents. Antimicrob Agents Chemother 23: 559–564
Author information
Authors and Affiliations
Additional information
Supported by the Veterans Administration
Rights and permissions
About this article
Cite this article
Frimodt-Møller, P.C., Dørflinger, T. & Madsen, P.O. Distribution of ciprofloxacin in the dog prostate and various tissues. Urol. Res. 12, 283–286 (1984). https://doi.org/10.1007/BF00258036
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00258036